Revolutionizing Medicine: Proteins to Combat Superbugs
A team of Australian scientists has utilized artificial intelligence to create proteins that can eliminate antibiotic-resistant bacteria, such as E. coli.
This innovation presents a new frontier in the fight against dangerous superbugs.
The findings were published in the scientific journal Nature Communications, as reported by ScienceDaily.
Dr. Rhys Grinter, a leading scientist overseeing the project, explained that traditionally, proteins for treating cancers or infections have been sourced from nature with minor modifications.
However, advancements in artificial intelligence now enable the creation of proteins "from scratch" with desired properties. This will reduce the costs of developing new medications and expedite the process.
Previously, scientists could spend decades designing a specific protein for a particular disease, but for AI, this task takes only seconds. In the past year, AI has generated many more proteins that could eventually treat a variety of ailments—from snake bites to cancer.
The team of Australian biologists and computer scientists has created, for the first time, proteins that destroy antibiotic-resistant bacteria. This development offers a novel approach to combating harmful superbugs.
With the use of AI, Australia now has a platform, similar to that of the USA or China, which can rapidly produce thousands of useful proteins, potentially transforming the healthcare landscape in the country.
The new protein development program using AI operates at the Bio21 Institute of the University of Melbourne and the Monash University Institute of Biomedical Discovery. It is led by Dr. Rhys Grinter and Associate Professor Gavin Nott.
They explain that their protein development platform using AI is based on the principles of Nobel Prize-winning chemist David Baker, who developed a method for creating a multitude of different proteins.
Associate Professor Nott adds, "These proteins are currently being turned into medicines, vaccines, tiny materials, and small sensors, as well as other products that will be tested in the future".
